AG
VCYT icon

Aperio Group’s Veracyte VCYT Stock Holding History

Aperio Group’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$315K Buy
+6,431
New +$298K ﹤0.01% 2165
2020
Q2 		– Sell
-10,820
Closed -$263K – 2392
2020
Q1 		$263K Sell
10,820
-463
-4% -$11.7K ﹤0.01% 1983
2019
Q4 		$315K Sell
11,283
-287
-2% -$7.43K ﹤0.01% 2044
2019
Q3 		$278K Buy
11,570
+4,017
+53% +$107K ﹤0.01% 2051
2019
Q2 		$215K Buy
+7,553
New +$189K ﹤0.01% 2153

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aperio Group's VCYT Position: Q4 2020 in Review

Aperio Group opened a new position in Veracyte (VCYT) in Q4 2020: 6,431 shares worth $315K. The stake represents ﹤0.01% of the portfolio and ranks #2165 among its holdings. This is a return to the name: Aperio Group previously reported a position in VCYT as recently as Q1 2020.

Aperio Group first reported a position in VCYT in Q2 2019 and has held it in 5 quarters since. 222 funds tracked by Wall St. Rank hold VCYT as of Q4 2020.

  • Aperio Group held 6,431 shares of Veracyte worth $315K as of Q4 2020.
  • Veracyte was a new Aperio Group position in Q4 2020.
  • Veracyte made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2165 holding.
  • Aperio Group first reported a position in Veracyte in Q2 2019 and has held it in 5 quarters since.
  • 222 funds tracked by Wall St. Rank held Veracyte as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.